Toponomics analysis of drug-induced changes in arachidonic acid-dependent signaling pathways during spinal nociceptive processing

Journal of Proteome Research

Volumn 8, Issue 10, 2009, Pages 4851-4859

  Linke, Bona ^a   Pierre, Sandra ^a   Coste, Ovidiu ^a   Angioni, Carlo ^a   Becker, Wiebke ^a   Maier, Thorsten Jürgen ^b   Steinhilber, Dieter ^b   Wittpoth, Claus ^c   Geisslinger, Gerd ^a   Scholich, Klaus ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b GOETHE UNIVERSITY   (Germany)

^c MelTec GmbH and Co KG   (Germany)

Author keywords

Arachidonic acid; Dipyrone; Immunohistochemistry; Lipoxygenase; Pain; Protein networks; Spinal cord; Toponome

Indexed keywords

ARACHIDONATE 12 LIPOXYGENASE; ARACHIDONATE 5 LIPOXYGENASE; ARACHIDONIC ACID; DIPYRONE; PROSTAGLANDIN SYNTHASE; ZYMOSAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; HYPERALGESIA; IMAGING AND DISPLAY; IMAGING SYSTEM; IMMUNOFLUORESCENCE MICROSCOPY; IMMUNOHISTOCHEMISTRY; MATHEMATICAL ANALYSIS; MOUSE; MULTI EPITOPE LIGAND CARTHOGRAPHY; NOCICEPTIVE STIMULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; SIGNAL TRANSDUCTION; SPINAL CORD;

ANIMALS; ARACHIDONATE 12-LIPOXYGENASE; ARACHIDONATE 5-LIPOXYGENASE; ARACHIDONIC ACID; DIPYRONE; IMMUNOHISTOCHEMISTRY; MICE; NOCICEPTORS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PROTEOME; PROTEOMICS; SIGNAL TRANSDUCTION; SPINAL CORD; STATISTICS, NONPARAMETRIC;

ANIMALIA; MUS;

EID: 70349971157     PISSN: 15353893     EISSN: None     Source Type: Journal    
DOI: 10.1021/pr900106v     Document Type: Article

References (39)

1. Friedenberger, M.; Bode, M.; Krusche, A.; Schubert, W. Fluorescence detection of protein clusters in individual cells and tissue sections by using toponome imaging system: sample preparation and measuring procedures. Nat. Protoc. 2007, 2 (9), 2285-2294 (Pubitemid 351565866)
2. Schubert, W.; Bonnekoh, B.; Pommer, A. J.; Philipsen, L.; Bockelmann, R.; Malykh, Y.; Gollnick, H.; Friedenberger, M.; Bode, M.; Dress, A. W. Analyzing proteome topology and function by automated multidimensional fluorescence microscopy. Nat. Biotechnol. 2006, 24 (10), 1270-1278
3. Berndt, U.; Bartsch, S.; Philipsen, L.; Danese, S.; Wiedenmann, B.; Dignass, A. U.; Hammerle, M.; Sturm, A. Proteomic analysis of the inflamed intestinal mucosa reveals distinctive immune response profiles in Crohn's disease and ulcerative colitis. J. Immunol. 2007, 179 (1), 295-304. (Pubitemid 46986545)
4. Berndt, U.; Philipsen, L.; Bartsch, S.; Wiedenmann, B.; Baumgart, D. C.; Hammerle, M.; Sturm, A. Systematic high-content proteomic analysis reveals substantial immunologic changes in colorectal cancer. Cancer Res. 2008, 68 (3), 880-888 (Pubitemid 351206766)
5. Bonnekoh, B.; Pommer, A. J.; Bockelmann, R.; Hofmeister, H.; Philipsen, L.; Gollnick, H. Topo-proteomic in situ analysis of psoriatic plaque under efalizumab treatment. Skin Pharmacol. Physiol. 2007, 20 (5), 237-252 (Pubitemid 47312678)
6. Pierre, S.; Maeurer, C.; Coste, O.; Becker, W.; Schmidtko, A.; Holland, S.; Wittpoth, C.; Geisslinger, G.; Scholich, K. Toponomic analysis of functional interactions of the ubiquitin ligase PAM during spinal nociceptive processing. Mol. Cell. Proteomics 2008, 7 (12), 2475-2485
7. Abbate, R.; Gori, A. M.; Pinto, S.; Attanasio, M.; Paniccia, R.; Coppo, M.; Castellani, S.; Giusti, B.; Boddi, M.; Neri Serneri, G. G. Cyclooxygenase and lipoxygenase metabolite synthesis by polymorphonuclear neutrophils: in vitro effect of dipyrone. Prostaglandins, Leukotrienes Essent. Fatty Acids 1990, 41 (2), 89-93. (Pubitemid 20325796)
8. Campos, C.; de Gregorio, R.; Garcia-Nieto, R.; Gago, F.; Ortiz, P.; Alemany, S. Regulation of cyclooxygenase activity by metamizol. Eur. J. Pharmacol. 1999, 378 (3), 339-347
9. Ayoub, S. S.; Botting, R. M.; Goorha, S.; Colville-Nash, P. R.; Willoughby, D. A.; Ballou, L. R. Acetaminophen-induced hypothermia in mice is mediated by a prostaglandin endoperoxide synthase 1 gene-derived protein. Proc. Natl. Acad. Sci. U.S.A. 2004, 101 (30), 11165-11169
10. Levy, M.; Brune, K.; Zylber-Katz, E.; Cohen, O.; Caraco, Y.; Geisslinger, G. Cerebrospinal fluid prostaglandins after systemic dipyrone intake. Clin. Pharmacol. Ther. 1998, 64 (1), 117-122 (Pubitemid 28377337)
11. Scholich, K.; Geisslinger, G. Is mPGES-1 a promising target for pain therapy. Trends Pharmacol. Sci. 2006, 27 (8), 399-401. (Pubitemid 44069583)
12. Geisslinger, G.; Peskar, B. A.; Pallapies, D.; Sittl, R.; Levy, M.; Brune, K. The effects on platelet aggregation and prostanoid biosynthesis of two parenteral analgesics: ketorolac tromethamine and dipyrone. Thromb. Haemostasis 1996, 76 (4), 592-597 (Pubitemid 26372016)
13. Pierre, S. C.; Schmidt, R.; Brenneis, C.; Michaelis, M.; Geisslinger, G.; Scholich, K. Inhibition of cyclooxygenases by dipyrone. Br. J. Pharmacol. 2007, 151 (4), 494-503.
14. Morath, R.; Klein, T.; Seyberth, H. W.; Nusing, R. M. Immunolocalization of the four prostaglandin E2 receptor proteins EP1, EP2, EP3, and EP4 in human kidney. J. Am. Soc. Nephrol. 1999, 10 (9), 1851-1860
15. Schmidtko, A.; Gao, W.; Sausbier, M.; Rauhmeier, I.; Sausbier, U.; Niederberger, E.; Scholich, K.; Huber, A.; Neuhuber, W.; Allescher, H. D.; Hofmann, F.; Tegeder, I.; Ruth, P.; Geisslinger, G. Cysteine-rich protein 2, a novel downstream effector of cGMP/cGMP-dependent protein kinase I-mediated persistent inflammatory pain. J. Neurosci. 2008, 28 (6), 1320-1330 (Pubitemid 351231528)
16. Brenneis, C.; Maier, T. J.; Schmidt, R.; Hofacker, A.; Zulauf, L.; Jakobsson, P. J.; Scholich, K.; Geisslinger, G. Inhibition of prostaglandin E2 synthesis by SC-560 is independent of cyclooxygenase 1 inhibition. FASEB J. 2006, 20 (9), 1352-1360 (Pubitemid 44943843)
17. Brenneis, C.; Coste, O.; Schmidt, R.; Angioni, C.; Popp, L.; Nusing, R. M.; Becker, W.; Scholich, K.; Geisslinger, G. Consequences of altered eicosanoid patterns for nociceptive processing in mPGES-1-deficient mice. J. Cell. Mol. Med. 2008, 12 (2), 639-648 (Pubitemid 351555141)
18. Fischer, L.; Szellas, D.; Radmark, O.; Steinhilber, D.; Werz, O. Phosphorylation- and stimulus-dependent inhibition of cellular 5-lipoxygenase activity by nonredox-type inhibitors. FASEB J. 2003, 17 (8), 949-951
19. Brungs, M.; Radmark, O.; Samuelsson, B.; Steinhilber, D. Sequential induction of 5-lipoxygenase gene expression and activity in Mono Mac 6 cells by transforming growth factor beta and 1,25-dihydroxyvitamin D3. Proc. Natl. Acad. Sci. U.S.A. 1995, 92 (1), 107-111
20. Werz, O.; Steinhilber, D. Selenium-dependent peroxidases suppress 5-lipoxygenase activity in B-lymphocytes and immature myeloid cells. The presence of peroxidase-insensitive 5-lipoxygenase activity in differentiated myeloid cells. Eur. J. Biochem. 1996, 242 (1), 90-97 (Pubitemid 26386360)
21. Nardi, M. A.; Gor, Y.; Feinmark, S. J.; Xu, F.; Karpatkin, S. Platelet particle formation by anti GPIIIa49-66 Ab, Ca2+ ionophore A23187, and phorbol myristate acetate is induced by reactive oxygen species and inhibited by dexamethasone blockade of platelet phospholipase A2, 12-lipoxygenase, and NADPH oxidase. Blood 2007, 110 (6), 1989-1996 (Pubitemid 47443913)
22. Hagmann, W.; Gao, X.; Zacharek, A.; Wojciechowski, L. A.; Honn, K. V. 12-Lipoxygenase in Lewis lung carcinoma cells: molecular identity, intracellular distribution of activity and protein, and Ca(2+)-dependent translocation from cytosol to membranes. Prostaglandins 1995, 49 (1), 49-62.
23. Radmark, O.; Werz, O.; Steinhilber, D.; Samuelsson, B. 5-Lipoxygenase: regulation of expression and enzyme activity. Trends Biochem. Sci. 2007, 32 (7), 332-341 (Pubitemid 47021417)
24. Trebino, C. E.; Eskra, J. D.; Wachtmann, T. S.; Perez, J. R.; Carty, T. J.; Audoly, L. P. Redirection of eicosanoid metabolism in mPGES-1-deficient macrophages. J. Biol. Chem. 2005, 280 (17), 16579-16585
25. Wang, M.; Zukas, A. M.; Hui, Y.; Ricciotti, E.; Pure, E.; FitzGerald, G. A. Deletion of microsomal prostaglandin E synthase-1 augments prostacyclin and retards atherogenesis. Proc. Natl. Acad. Sci. U.S.A. 2006, 103 (39), 14507-14512 (Pubitemid 44484780)
26. Chen, C. J.; Huang, H. S.; Lin, S. B.; Chang, W. C. Regulation of cyclooxygenase and 12-lipoxygenase catalysis by phospholipid hydroperoxide glutathione peroxidase in A431 cells. Prostaglandins, Leukotrienes, Essent. Fatty Acids 2000, 62 (4), 261-268 (Pubitemid 30410533)
27. Wang, M. X.; Wei, A.; Yuan, J.; Trickett, A.; Knoops, B.; Murrell, G. A. Expression and regulation of peroxiredoxin 5 in human osteoarthritis. FEBS Lett. 2002, 531 (2), 359-362 (Pubitemid 35341224)
28. Huang, X.; Moir, R. D.; Tanzi, R. E.; Bush, A. I.; Rogers, J. T. Redoxactive metals, oxidative stress, and Alzheimer's disease pathology. Ann. N.Y. Acad. Sci. 2004, 1012, 153-163 (Pubitemid 38453522)
29. Imlay, J. A. Pathways of oxidative damage. Annu. Rev. Microbiol. 2003, 57, 395-418.
30. Aley, O.; Levine, J. D. Contribution of 5- and 12-lipoxygenase products to mechanical hyperalgesia induced by prostaglandin E(2) and epinephrine in the rat. Exp. Brain Res. 2003, 148 (4), 482-487
31. Leone, S.; Ottani, A.; Bertolini, A. Dual acting anti-inflammatory drugs. Curr. Top. Med. Chem. 2007, 7 (3), 265-275
32. Nogueira-Neto, F. D.; Amorim, R. L.; Brigatte, P.; Picolo, G.; Ferreira, W. A.; Gutierrez, V. P.; Conceicao, I. M.; Della-Casa, M. S.; Takahira, R. K.; Nicoletti, J. L.; Cury, Y. The analgesic effect of crotoxin on neuropathic pain is mediated by central muscarinic receptors and 5-lipoxygenase-derived mediators. Pharmacol. Biochem. Behav. 2008, 91 (2), 252-260
33. Christie, M. J.; Connor, M.; Vaughan, C. W.; Ingram, S. L.; Bagley, E. E. Cellular actions of opioids and other analgesics: implications for synergism in pain relief. Clin. Exp. Pharmacol. Physiol. 2000, 27 (7), 520-523
34. Tornhamre, S.; Elmqvist, A.; Lindgren, J. A. 15-Lipoxygenation of leukotriene A(4). Studies Of 12- and 15-lipoxygenase efficiency to catalyze lipoxin formation. Biochim. Biophys. Acta 2000, 1484 (2-3), 298-306.
35. Romano, M. Lipid mediators: lipoxin and aspirin-triggered 15-epilipoxins. Inflammation Allergy: Drug Targets 2006, 5 (2), 81-90. (Pubitemid 43796670)
36. Tjonahen, E.; Oh, S. F.; Siegelman, J.; Elangovan, S.; Percarpio, K. B.; Hong, S.; Arita, M.; Serhan, C. N. Resolvin E2: identification and anti-inflammatory actions: pivotal role of human 5-lipoxygenase in resolvin E series biosynthesis. Chem. Biol. 2006, 13 (11), 1193-1202
37. Serhan, C. N.; Chiang, N.; Van Dyke, T. E. Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat. Rev. Immunol. 2008, 8 (5), 349-361
38. Ariel, A.; Serhan, C. N. Resolvins and protectins in the termination program of acute inflammation. Trends Immunol. 2007, 28 (4), 176-183
39. Ye, Y.; Lin, Y.; Perez-Polo, J. R.; Uretsky, B. F.; Ye, Z.; Tieu, B. C.; Birnbaum, Y. Phosphorylation of 5-lipoxygenase at ser523 by protein kinase A determines whether pioglitazone and atorvastatin induce proinflammatory leukotriene B4 or anti-inflammatory 15-epi-lipoxin a4 production. J. Immunol. 2008, 181 (5), 3515-3523